Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Journal Paper/Review - Oct 5, 2022
Panje Cédric, Hayoz Stefanie, Eisterer Wolfgang, Hess Viviane, Thuss-Patience Peter, Schacher Sabina, Dürr Donat, Wagner Anna Dorothea, Girschikofsky Michael, Eboulet Eric I, Stahl Michael, Ruhstaller Thomas
Recurrent oesophageal cancer after the initial curative multimodality treatment is a disease condition with a poor prognosis. There is limited evidence on recurrence patterns and on the optimal therapeutic approach.